08045804946
medisus.pharma007@gmail.com
Change Language
TUCALIV 150MG

TUCALIV 150MG

29999.0 INR/Unit

Product Details:

  • Origin of Medicine INDIA
  • Brand Name TUCALIV 150MG
  • Ingredients Active IngredientTucatinib: 150 mg per tabletInactive Ingredients1. Tablet Core:CopovidoneCrospovidoneSodium chloridePotassium chlorideSodium bicarbonateColloidal silicon dioxideMagnesium stearateMicrocrystalline cellulose2. Tablet Coating (Yellow Film Coat):Polyvinyl alcoholTitanium dioxideMacrogol/polyethylene glycolTalcYellow iron oxide (non-irradiated)
  • Physical Form Capsules
  • Dosage 150MG
  • Suitable For Women, Adults, Aged Person
  • Quantity 60 Boxes
  • Click to View more
X

TUCALIV 150MG Price And Quantity

  • 29999.0 INR/Unit
  • 10 Bottle

TUCALIV 150MG Product Specifications

  • INDIA
  • Active IngredientTucatinib: 150 mg per tabletInactive Ingredients1. Tablet Core:CopovidoneCrospovidoneSodium chloridePotassium chlorideSodium bicarbonateColloidal silicon dioxideMagnesium stearateMicrocrystalline cellulose2. Tablet Coating (Yellow Film Coat):Polyvinyl alcoholTitanium dioxideMacrogol/polyethylene glycolTalcYellow iron oxide (non-irradiated)
  • 150MG
  • Women, Adults, Aged Person
  • Capsules
  • TUCALIV 150MG
  • 60 Boxes

TUCALIV 150MG Trade Information

  • 2 Days

Product Description

Key Product and Clinical Details
Physical Appearance & Formulation
  • Form: Film-coated, oval-shaped yellow tablets.
  • Debossing: Typically debossed with TUC on one side and 150 on the other.
  • Dimensions: Approximately 17 mm in length and 7 mm in width. 
How It Works
  • Classification: Tyrosine kinase inhibitor (TKI); it is not a traditional chemotherapy drug.
  • Action: Selectively targets and blocks the HER2 receptor, halting the downstream signaling pathways that allow cancer cells to grow and multiply.
  • Brain Penetration: It is uniquely capable of crossing the blood-brain barrier, making it highly effective against central nervous system metastases. 
Approved Indications & Dosage
  • Breast Cancer: Indicated in combination with trastuzumab and capecitabine for adults with locally advanced or metastatic HER2-positive breast cancer.
  • Colorectal Cancer: Also used in combination with trastuzumab for RAS wild-type, HER2-positive metastatic colorectal cancer.
  • Standard Dosage: The typical recommended dose is 300 mg (two 150 mg tablets) taken twice daily, roughly 12 hours apart. 
Important Safety & Administration
  • How to Take: Swallow the tablets whole with water. Do not chew, crush, split, or dissolve them.
  • Food Intake: It can be taken with or without food.
  • Common Side Effects: Diarrhea, nausea, vomiting, mouth sores, fatigue, rash, and hand-foot syndrome.
  • Monitoring: Regular liver function tests and monitoring for severe diarrhea or dehydration are generally required during treatment.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Medicines' category



Back to top